A randomized, open label, cross-over comparative study of irbesartan/hydrochlorothiazide and irbesartan in the treatment of mild to moderate hypertension.
Phase of Trial: Phase IV
Latest Information Update: 22 Sep 2009
At a glance
- Drugs Irbesartan; Irbesartan/hydrochlorothiazide
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 06 Nov 2008 Actual patient number (60) added as reported by ClinicalTrials.gov.
- 06 Nov 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.